CS logo
small CS logo
MVZ Kloster Paradiese GbR

Soest, Germany
Hospital in North Rhine-Westphalia
Im Stiftsfeld 1, 59494 Soest

About MVZ Kloster Paradiese GbR


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
iOMEDICO AG
3
IFAG AG
2
Pfizer
1
University Hospital Tuebingen
1
Total Rows: 4

Clinical Trials at MVZ Kloster Paradiese GbR


During the past decade, MVZ Kloster Paradiese GbR conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110000001122000000000000Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
2008-02-13
2021-12-28
Completed
1,520
Iscador Qu as Supportive Treatment in Colorectal Cancer (Union International Cancer Control, UICC Stages II-IV)
2010-09-01
2017-06-01
Unknown status
300
Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV)
2010-09-01
2016-06-01
Unknown status
220
Therapy Management With Nab-Paclitaxel in Daily Routine
2015-12-01
2021-12-01
Unknown status
1,200
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
2019-07-10
2021-07-01
Completed
154
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
2020-04-17
2023-06-30
Recruiting
500
Registry for Molecular Testing, Treatment and Outcome of Patients With Solid Tumors Harboring a NTRK Gene Fusion
2020-12-02
2026-10-25
Recruiting
120

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ Kloster Paradiese GbR" #1 collaborator was "Roche Pharma AG" with 3 trials as a collaborator, "Hiscia Society for Cancer Research" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "IFAG Basel AG (CRO), both Switzerland" with 1 trials as a collaborator and "IFAG Basel AG, both Switzerland" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsiOMEDICO AG: 3iOMEDICO AG: 3IFAG AG: 2IFAG AG: 2Pfizer: 1Pfizer: 1University Hospital Tuebingen: 1University Hospital Tuebingen: 1

Created with Highcharts 11.1.0Top CollaboratorsRoche Pharma AG: 3Roche Pharma AG: 3Hiscia Society forCancer Research: 2Hiscia Society forCancer Research: 2Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1IFAG Basel AG (CRO),both Switzerland: 1IFAG Basel AG (CRO),both Switzerland: 1IFAG Basel AG, bothSwitzerland: 1IFAG Basel AG, bothSwitzerland: 1

Clinical Trials Conditions at MVZ Kloster Paradiese GbR


According to Clinical.Site data, the most researched conditions in "MVZ Kloster Paradiese GbR" are "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Carcinoma, Renal Cell, Advanced" (1 trials), "Colorectal Cancer" (1 trials) and "Extensive-stage Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "MVZ Kloster Paradiese GbR" in a lesser frequency.

Clinical Trials Intervention Types at MVZ Kloster Paradiese GbR


Most popular intervention types in "MVZ Kloster Paradiese GbR" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Axitinib" (1 trials), "Sunitinib" (1 trials), "Temsirolimus" (1 trials) and "eHealth system support for symptom management via CANKADO" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MVZ Kloster Paradiese GbR


The vast majority of trials in "MVZ Kloster Paradiese GbR" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at MVZ Kloster Paradiese GbR


Currently, there are NaN active trials in "MVZ Kloster Paradiese GbR". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MVZ Kloster Paradiese GbR, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MVZ Kloster Paradiese GbR, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials StatusUnknown status: 3Unknown status: 3Completed: 2Completed: 2Recruiting: 2Recruiting: 2